Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
Crossref DOI link: https://doi.org/10.1136/bmjdrc-2016-000227
Published Online: 2016-08-04
Published Print: 2016-08
Update policy: https://doi.org/10.1136/crossmarkpolicy
Birnbaum, Yochai
Bajaj, Mandeep
Qian, Jinqiao
Ye, Yumei
Funding for this research was provided by:
AstraZeneca
American Diabetes Association (07-13-TS-04)
